Brevan Howard Capital Management’s GeneDx Holdings WGS Stock Holding History

Brevan Howard Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	28,172 +22,506	+397%	+$1.28M	0.01%	728
2026 Q1	$364K	Buy	5,666 +3,130	+123%	+$285K	﹤0.01%	1486
2025 Q4	$330K	Sell	2,536 -2,664	-51%	-$366K	﹤0.01%	1319
2025 Q3	$560K	Buy	+5,200	New	+$567K	﹤0.01%	1227

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Brevan Howard Capital Management's WGS Position: Q2 2026 in Review

Brevan Howard Capital Management increased its GeneDx Holdings (WGS) stake by 397% in Q2 2026, buying an estimated $1.28M and bringing the position to 28,172 shares worth $1.93M. The position accounts for 0.01% of the portfolio, ranked #728.

Brevan Howard Capital Management first reported a position in WGS in Q3 2025 and has held it in 4 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Brevan Howard Capital Management held 28,172 shares of GeneDx Holdings worth $1.93M as of Q2 2026.
Brevan Howard Capital Management bought 22,506 GeneDx Holdings shares in Q2 2026, an estimated $1.28M.
GeneDx Holdings made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #728 holding.
Brevan Howard Capital Management first reported a position in GeneDx Holdings in Q3 2025 and has held it in 4 quarters since.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.